ClinConnect ClinConnect Logo
Search / Trial NCT03931707

The China Neonatal Genomes Project

Launched by CHILDREN'S HOSPITAL OF FUDAN UNIVERSITY · Apr 28, 2019

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Newborn Hereditary Disease Genetic Predisposition To Disease Defect, Congenital Genome Sequencing Exome Sequencing Newborn Screening Genetic Diseases, Inborn

ClinConnect Summary

The China Neonatal Genomes Project is an important study that aims to understand the genetic makeup of newborns in China. Over the next five years, researchers plan to conduct genetic testing on 100,000 babies to create a comprehensive database that can help identify and manage hereditary diseases—conditions that can be passed down from parents to their children. By establishing standards for testing these genetic conditions, the project hopes to improve how we understand and treat genetic diseases in newborns, as well as enhance the training for professionals who provide genetic counseling to families.

To participate in this study, babies must be less than 28 days old and have parents of Chinese origin. It's essential that the baby's parents or guardians agree to take part by providing informed consent. Participants can expect a simple blood sample to be taken for genetic testing, which will help researchers gather valuable information. If you're interested in this study, it's important to note that it does not include babies from certain backgrounds or those who cannot provide a blood sample. This project is a step towards better understanding and addressing genetic diseases in newborns, ultimately aiming to improve health outcomes for future generations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Both parents are of Chinese origin;
  • 2. Postnatal age less than 28 days;
  • 3. Can be retained to at least 1ml venous blood sample;
  • 4. Biological parent or guardian's informed consent.
  • Exclusion Criteria:
  • 1. the nationality of one of the parents is not the Han nationality or other national minorities;
  • 2. reluctance of parents to use genetic sequencing data for subsequent research;
  • 3. parents under 18 years of age or incapacitated for decision-making;
  • 4. subjects older than 28 days.
  • 5. multiple pregnancies;
  • 6. lack of access to biological samples from which DNA can be extracted;
  • 7. failure to sign informed consent

About Children's Hospital Of Fudan University

The Children's Hospital of Fudan University is a leading pediatric healthcare institution in China, renowned for its commitment to advancing child health through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital focuses on conducting high-quality, ethically-driven studies that aim to improve pediatric care and treatment outcomes. With a multidisciplinary team of experienced healthcare professionals and researchers, the hospital leverages its robust infrastructure and expertise to facilitate groundbreaking clinical trials, ensuring the safety and well-being of child participants while contributing valuable insights to the global medical community.

Locations

Shanghai, Shanghai, China

Patients applied

0 patients applied

Trial Officials

Wenhao Zhou

Study Chair

Children's Hospital of Fudan University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials